Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
An analysis of volatility between Total Market and SP 500 funds in retirement contexts, addressing risk tolerance and safeguard strategies.
28,209 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Buffett’s longest-running wager sits in plain sight: a simple, legendary drink that built a fortress around its brand...
Five AI models were asked whether Bitcoin would top $100,000 again in 2026. Four forecast a rebound above that level,...
Mel Robbins, the millionaire podcaster, pushes back against the Gen Z lazy stereotype, arguing that today’s young wor...
Micron Technology has surged in 2026, adding roughly a trillion dollars to its market value. But two wild cards—memor...
Finassets unveils a bold overhaul of its crypto affiliate program, boosting first-year partner earnings and locking i...
When a tech giant inks a massive AI deal, stock moves follow. This analysis explains why neb ius stock popped today, ...
Driven Brands generated $1.9 billion in revenue, signaling a powerful multi-brand approach in the auto aftermarket. B...
Snap aims to redefine how we interact with the world through AR glasses, but can this gadget lift the stock? This gui...
AlleyCorp unveils a new $335 million fund focused on early-stage bets in healthcare and technology. The move reinforc...
A major new stake in Virtu Financial is drawing attention from investors. This guide explains the numbers behind the ...
A clear, investor-friendly look at arcosa (aca) 2025 earnings through the lens of the Q4 2025 earnings call. Learn wh...